Company / Current Liabilities
Traws Pharma, Inc. Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$11.1M
FY2024
5-year range
$6.1M / $11.1M
FY2020-FY2024
Trend
+20.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 3 consecutive years, from $6M in FY2021 to $11M in FY2024.
Based on SEC 10-K filings.
$11M in FY2024 with a 5-year CAGR of +6.1%.
Increased from $8M to $11M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +22.2%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Traws Pharma, Inc.'s current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2024, current liabilities increased 20.9% year-over-year.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $11.1M | +20.9% |
| FY2023 | $9.2M | +14.6% |
| FY2022 | $8.0M | +31.6% |
| FY2021 | $6.1M | -39.0% |
| FY2020 | $10.0M | +20.9% |
| FY2019 | $8.3M | -1.7% |
| FY2018 | $8.4M | -15.4% |
| FY2017 | $10.0M | -1.8% |
| FY2016 | $10.2M | +33.6% |
| FY2015 | $7.6M | -25.9% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026